These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27668766)

  • 41. Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia.
    Xu LP; Zhang XH; Wang FR; Mo XD; Han TT; Han W; Chen YH; Zhang YY; Wang JZ; Yan CH; Sun YQ; Zuo SN; Huang XJ
    Bone Marrow Transplant; 2017 Mar; 52(3):381-387. PubMed ID: 27941773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matched related donor hematopoietic stem cell transplantation results in a long-term follow-up of a pediatric acquired severe aplastic anemia subset: A stem cell source perspective.
    Hamidieh AA; Mozafari M; Noshad S; Alimoghaddam K; Behfar M; Ghavamzadeh A
    Pediatr Transplant; 2015 Jun; 19(4):399-407. PubMed ID: 25824340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
    Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
    Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of aplastic anemia after failure of frontline immunosuppression.
    Pierri F; Dufour C
    Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnosis and treatment of children with aplastic anemia.
    Kurre P; Johnson FL; Deeg HJ
    Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoietic stem cell transplantation without in vivo T-cell depletion for pediatric aplastic anemia: A single-center experience.
    Li S; Wang B; Fu L; Pang Y; Zhu G; Zhou X; Ma J; Su Y; Qin M; Wu R
    Pediatr Transplant; 2018 Aug; 22(5):e13204. PubMed ID: 29744996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
    Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
    Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
    Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
    J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
    Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hematopoietic stem cell transplantation for acquired aplastic anemia.
    Georges GE; Storb R
    Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.
    Bacigalupo A; Marsh JC
    Bone Marrow Transplant; 2013 Feb; 48(2):198-200. PubMed ID: 23178545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-existing anti-HLA antibodies negatively impact survival of pediatric aplastic anemia patients undergoing HSCT.
    Zhu H; He J; Cai J; Yuan X; Jiang H; Luo C; Wang J; Luo C; Pan Z; Terasaki PI; Ding L; Chen J
    Clin Transplant; 2014 Nov; 28(11):1225-33. PubMed ID: 25123053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [HLA- haploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLA- unrelated donor transplantation].
    Lu Y; Wu T; Cao X; Zhao Y; Liu D; Sun R; Xiong M; Wei Z; Zhang J; Zhou J; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):35-8. PubMed ID: 26876251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
    Kudo K; Muramatsu H; Yoshida N; Kobayashi R; Yabe H; Tabuchi K; Kato K; Koh K; Takahashi Y; Hashii Y; Kawano Y; Inoue M; Cho Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
    Bone Marrow Transplant; 2015 Oct; 50(10):1312-5. PubMed ID: 26121106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.
    Ngwube A; Hayashi RJ; Murray L; Loechelt B; Dalal J; Jaroscak J; Shenoy S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1270-6. PubMed ID: 25755151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative donor HSCT in refractory acquired aplastic anemia - prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation.
    Urban C; Benesch M; Sovinz P; Sipurzynski S; Lackner H; Müller E; Schwinger W
    Pediatr Transplant; 2012 Sep; 16(6):577-81. PubMed ID: 22462513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haematopoietic stem cell transplantation for acquired aplastic anaemia.
    Young ME; Potter V; Kulasekararaj AG; Mufti GJ; Marsh JC
    Curr Opin Hematol; 2013 Nov; 20(6):515-20. PubMed ID: 24104412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
    Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.